Detalhe da pesquisa
1.
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
N Engl J Med
; 387(2): 132-147, 2022 07 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660812
2.
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(10): 1317-1330, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32866432
3.
A phase 2 trial of abiraterone acetate without glucocorticoids for men with metastatic castration-resistant prostate cancer.
Cancer
; 125(4): 524-532, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30427533
4.
Treatments for newly diagnosed multiple myeloma: when endurance is interrupted - Authors' reply.
Lancet Oncol
; 21(12): e541, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33271098
5.
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone.
Blood
; 118(16): 4359-62, 2011 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21860025
6.
Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.
Br J Haematol
; 155(3): 340-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21902684